RxDoctor Payments Data

Michael Christie, MD

Orthopaedic Surgery · Nashville, TNNPI 1841255346

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $468,275 of the $474,221 with a category attached, or 98.7%. Depuy Synthes Products, Inc. accounts for 98.7% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $113,864 and has fallen 99.2% since, to $961 in 2025. Among orthopaedic surgery clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$474,221in general payments, 2019–2025

Across 54 payments — averaging $8781.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$468K
  • Medical Device Business Services, Inc.$4K
  • Medacta USA, Inc.$557
  • Stryker$350
  • Smith+Nephew$308
  • Johnson & Johnson$241
  • plus $862 from 8 others
$108,725in research payments, 2019–2025

Across 23 payments — averaging $4727.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$66K
  • Smith+Nephew$43K

What the payments were for

  • Royalty or licence$468,27599%
  • Consulting fees$3,5101%
  • Food & beverage$2,4371%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$474,221 in reported general payments places this provider in the 95th percentile of 381 orthopaedic surgery providers in Tennessee.

See all orthopaedic surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$236,181
Medicare patients
324
Services billed
1,858

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tranexamic Acid18$590
Meloxicam151$402
Oxycodone Hcl51$326
Cephalexin23$288
Celecoxib15$180
Pantoprazole Sodium19$123
Amoxicillin60$105
Ondansetron Hcl20$82
Dexamethasone12$20

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →